MACK Historical Earnings image   This MACK historical earnings page last updated 11/7/2022
MACK Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/3/2022NA
Q2 20228/4/2022NA
Q1 20225/5/2022NA
Q4 20213/9/2022NA
Q3 202111/4/2021NA
Q2 20218/5/2021NA
Q1 20215/6/2021NA
Q4 20203/10/2021NA
Q3 202011/4/2020NA
Q2 20208/7/2020NA
Q1 20205/7/2020NA
Q4 20193/12/2020NA
Q3 201911/12/2019NA
Q2 20197/17/2019NA
Q1 20195/10/2019NA
Q4 20183/6/2019NA
Q3 201811/7/2018NA
Q2 20188/7/2018NA
Q1 20185/8/2018NA
Q4 20173/12/2018NA
Q3 201711/8/2017NA
Q2 20178/9/2017NA
Q1 20175/10/2017NA
Q4 20163/1/201761.24M
Q3 201611/9/201628.07M
Q2 20168/4/201633.68M
Q1 20165/2/201621.28M
Q4 20152/25/201621.42M
Q3 201511/9/201516.44M
Q2 20158/10/201536.56M
Q1 20155/7/201514.84M
Q4 20142/26/201533.91M
Q3 201411/10/201428.00M
Q2 20148/11/201427.80M
Q1 20145/1/201413.03M
Q4 20132/27/20147.82M
Q3 201311/7/20136.86M
Q2 20138/8/201318.50M
Q1 20135/13/201314.70M
Q4 20123/14/201314.20M
MACK Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/3/2022-0.030
Q2 20228/4/2022-0.040
Q1 20225/5/2022-0.010
Q4 20213/9/2022-0.030
Q3 202111/4/2021-0.040
Q2 20218/5/2021-0.060
Q1 20215/6/2021-0.050
Q4 20203/10/2021-0.080
Q3 202011/4/2020-0.080
Q2 20208/7/2020-0.090
Q1 20205/7/20200.020
Q4 20193/12/2020-0.050
Q3 201911/12/2019-0.210
Q2 20197/17/2019-0.710
Q1 20195/10/2019-0.780
Q4 20183/6/2019-0.97
Q3 201811/7/2018-0.92
Q2 20188/7/2018-1.33
Q1 20185/8/2018-1.33
Q4 20173/12/2018-0.89
Q3 201711/8/2017-0.4
Q2 20178/9/2017-2.200
Q1 20175/10/2017-2.200
Q4 20163/1/2017-2.500
Q3 201611/9/2016-2.300
Q2 20168/4/2016-4.000
Q1 20165/2/2016-3.300
Q4 20152/25/2016-4.100
Q3 201511/9/2015-3.800
Q2 20158/10/2015-2.100
Q1 20155/7/2015-3.200
Q4 20142/26/2015-0.900
Q3 201411/10/2014-2.700
Q2 20148/11/2014-1.700
Q1 20145/1/2014-2.700
Q4 20132/27/2014-3.300
Q3 201311/7/2013-3.900
Q2 20138/8/2013-3.100
Q1 20135/13/2013-2.900
Q4 20123/14/2013-2.600
Quotes delayed 20 minutes

Email EnvelopeFree MACK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Merrimack Pharmaceuticals (MACK) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MASI Historical Earnings
MBIO Historical Earnings
MBOT Historical Earnings
MBRX Historical Earnings
MCK Historical Earnings
MCRB Historical Earnings
MD Historical Earnings
MDGL Historical Earnings
MDT Historical Earnings
MDXG Historical Earnings
What was the record high MACK historical earnings result?
In terms of earnings or revenue, what is the best MACK historical earnings result that Merrimack Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest MACK historical earnings result was set in Q1 2020, when Merrimack Pharmaceuticals posted results of 0.020/share. The most successful revenue quarter within our data set was Q4 2016 when Merrimack Pharmaceuticals reported revenue of 61.24M.

What was the lowest Merrimack Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest MACK has reported, and when?

✔️Accepted answer: Within our data set, the lowest MACK historical earnings result was set in Q4 2015, when Merrimack Pharmaceuticals posted results of -4.100/share. The smallest revenue quarter within our data set was Q3 2022 when Merrimack Pharmaceuticals reported revenue of NA.

On this page we presented the MACK historical earnings date information for Merrimack Pharmaceuticals. Reviewing that MACK Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2020, when MACK posted gaap of 0.020/share. Meanwhile the lowest MACK historical earnings result was in Q4 2015, when MACK posted gaap of -4.100/share. Moving to Merrimack Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2016 when MACK reported 61.24M in revenue, while the smallest revenue quarter was Q3 2022 when MACK reported NA in revenue.

For self directed investors doing their due diligence on MACK or any other given stock, their research can benefit from looking into all of the Merrimack Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Merrimack Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for MACK. Thanks for visiting, and the next time you need to research MACK historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding LORL, Cohu Historical Earnings, Institutional Holders of EAST.

 

MACK Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.